Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2024Open Access

Plasma amyloid-β biomarkers for predicting amyloid positivity in mild cognitive impairment: a prospective cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

TATakuya AtakaNKNoriyuki KimuraNKNaoki Kaneko

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ataka et al. (2024) studied this question.

synapsesocial.com/papers/68e6a135b6db643587624767https://doi.org/10.21203/rs.3.rs-4361497/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals2025
  2. 2Predicting Longitudinal Cognitive Decline and Alzheimer’s Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers2024 · 16 citations
  3. 3Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients2024 · 12 citations
  4. 4Incremental value of plasma biomarkers in predicting clinical decline among cognitively unimpaired older adults: Results from the A4 trial2026 · 3 citations
  5. 5Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment2024 · 16 citations